Should You Buy Berkshire Hathaway Stock Before Feb. 27?

Berkshire Hathaway will report quarterly results in late February, marking the first update since Warren Buffett ceded the CEO role to Greg Abel; Buffett remains chairman. Abel has signaled a more active approach, including potential sales of the large Kraft Heinz stake, though no timeline has been set. Berkshire entered Q3 2025 with more than $380 billion in cash and short-term investments, providing a substantial cushion for acquisitions or strategic shifts. The transition is expected to be incremental rather than disruptive, but investors will watch Abel’s early decisions and commentary for indications of any material strategy changes.

Analysis

Market structure: Berkshire’s change in CEO primarily redistributes optionality rather than fundamentals — $380bn+ cash (Q3 2025) gives Abel scope to deploy $50–200bn over 12–36 months into buybacks, debt purchases or M&A, which would bid equities and corporate credit. Immediate winners: acquirable cyclical industrials/financials and banks that could be targets or beneficiaries of large strategic deals; losers: Kraft Heinz (KHC) equity if BRK begins phased selling, pressuring supply and implied volatility. Expect modest idiosyncratic equity volatility around the late-Feb earnings call (days–weeks) rather than marketwide dislocations.

Risk assessment: Tail risks include a rapid, taxable dump of KHC (20–40% downside), a large hostile acquisition that triggers antitrust scrutiny, or a capital misallocation >$100bn causing multi-quarter EPS drag. Near-term (0–30 days) risk is headline-driven sentiment; medium-term (3–12 months) risk centers on deployment choices and insurance float trends. Hidden dependencies: Buffett’s retained chair role constrains radical moves, and insurance float + interest rates drive capital availability and timing.

Trade implications: Direct plays: small core long BRK.B (1–3%) to capture optionality and downside protection from cash; short/put-spread on KHC to express likely pressure if stake liquidation begins. Pair trades: long BRK.B vs short XLP/KHC to bet on rotation from staples to industrials/financials. Use directional call spreads on BRK.B (3–9 month expiries) and defined-risk put spreads on KHC to control tail exposure.

Contrarian angles: Consensus fears of a Buffett-less BRK are likely overblown; market may underprice the probability of meaningful M&A (> $10–30bn) in the next 12–24 months. Conversely, selling KHC could signal capitulation and invite activist arbitrage that re-rates KHC or forces a breakup — so short sizing should be calibrated (target 20–40% move) and monitored for insider-driven timing signals around filings and block trades.

Key Decisions for Investors

• Establish a 1.5–3.0% long position in BRK.B within the next 2 weeks ahead of the late-Feb earnings call to capture acquisition/buyback optionality; set a tactical trim if no material capital allocation announcement within 60 days or if price falls >12%.
• Initiate a bearish position on KHC via a 6–9 month put spread sized to 1–2% of portfolio (e.g., buy 6–9m put, sell lower strike put to finance) targeting 20–40% downside; increase allocation if SEC filings or 13F/13D indicate an imminent block sale within 30 days.
• Execute a pair trade: long BRK.B 2.0% / short XLP or KHC 1.5% to express rotation out of consumer staples into conglomerate-capitalized cyclicals; rebalance after 90 days or upon a BRK acquisition >$10bn.
• Deploy options risk-defined strategies: buy a BRK.B 6–9 month call spread (cost ≤1.0% portfolio notional) to lever upside from M&A/buybacks, and sell KHC short-dated covered calls only if implied vol is > historical vol by 30% to monetize elevated premium.